SCHEMBL20015166

SCHEMBL20015166

CC1CN(C2OC2C)CC(C)N1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24700443 0.69 CYP2C9 (0.41) CYP2C9TSHRCYP2C19TDP1
Fluoride SCHEMBL11256207 0.67 TP53 (0.36)
SCHEMBL25690956 0.67
Hydrochloric Acid SCHEMBL23123878 0.67 CYP2C9 (0.39) CYP2C9TSHRCYP2C19TDP1
SCHEMBL19318257 0.65
SCHEMBL18256132 0.64
SCHEMBL24342600 0.64
SCHEMBL14110736 0.64
SCHEMBL81819 0.64
SCHEMBL13116775 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174881-B1 [1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2018-03-28 EP disclosed